|
ENTPD4 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.588000E-04 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.033910E-04 |
| Normal-vs-Stage2 |
2.767600E-01 |
| Normal-vs-Stage3 |
2.373800E-02 |
| Normal-vs-Stage4 |
1.021650E-01 |
| Stage1-vs-Stage2 |
3.010200E-01 |
| Stage1-vs-Stage3 |
7.377000E-01 |
| Stage1-vs-Stage4 |
4.386800E-01 |
| Stage2-vs-Stage3 |
5.434800E-01 |
| Stage2-vs-Stage4 |
2.873200E-01 |
| Stage3-vs-Stage4 |
4.144200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.417300E-04 |
| Normal-vs-AfricanAmerican |
4.638300E-03 |
| Normal-vs-Asian |
1.035270E-03 |
| Caucasian-vs-AfricanAmerican |
7.935200E-01 |
| Caucasian-vs-Asian |
3.124200E-01 |
| AfricanAmerican-vs-Asian |
3.363200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.89066999999321E-05 |
| Normal-vs-Female |
9.413600E-01 |
| Male-vs-Female |
5.449000E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.308300E-02 |
| Normal-vs-Extreme_Weight |
5.23109999983618E-07 |
| Normal-vs-Obese |
6.821600E-02 |
| Normal-vs-Extreme_Obese |
1.033770E-01 |
| Normal_Weight-vs-Extreme_Weight |
1.832010E-01 |
| Normal_Weight-vs-Obese |
4.661000E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.969400E-01 |
| Extreme_Weight-vs-Obese |
8.523800E-03 |
| Extreme_Weight-vs-Extreme_Obese |
5.618400E-01 |
| Obese-vs-Extreme_Obese |
4.621600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.934800E-01 |
| Normal-vs-Age(41-60Yrs) |
2.610100E-02 |
| Normal-vs-Age(61-80Yrs) |
1.594210E-04 |
| Normal-vs-Age(81-100Yrs) |
4.84690000024379E-07 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.364000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.298100E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.480100E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.791500E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.003000E-04 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.201600E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
7.50330000000021E-05 |
| Normal-VS-Type2 PRCC |
3.73350000000272E-05 |
| Normal-VS-KIRP CIMP |
3.636400E-01 |
| Normal-VS-Unclassified PRCC |
8.525200E-01 |
| Type1 PRCC-VS-Type2 PRCC |
4.897400E-01 |
| Type1 PRCC-VS-KIRP CIMP |
7.647700E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
7.697300E-03 |
| Type2 PRCC-VS-KIRP CIMP |
5.919700E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
3.275500E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
2.291400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.53990999999243E-05 |
| Normal-vs-N1 |
1.283030E-01 |
| Normal-vs-N2 |
7.394400E-01 |
| N0-vs-N1 |
1.984390E-01 |
| N0-vs-N2 |
3.427200E-01 |
| N1-vs-N2 |
2.786400E-01 |
|
|
